CEACAM5 and breast cancer: Previous studies on cancer biomarkers for breast cancer (15) have demonstrated that their low sensitivity and specificity prevent from the use of serum markers such as the MUC-1 mucin glycoproteins (CA 15.3, BR 27.29) and carcinoembryonic antigen (CEA) for the diagnosis of early breast cancer.